When one looks at the independent literature, so, studies which are not sponsored by the vaccine manufactures… with relation to Gardasil, there have been several reports documenting multiple sclerosis and encephalitis,1 which is brain inflammation, in girls who have received their Gardasil vaccine. So, just because a study sponsored by the manufactures does not identify problems with the vaccine, does not necessarily mean that the vaccine is safe. In fact if one looks at the manufacturer studies, they’re often not designed to detect serious adverse events.2
The quote above comes from Dr. Lucija Tomlinjenovic, a post-doctoral research fellow at the University of British Colombia. She’s published many papers on the efficacy and safety of HPV vaccines.
It’s a great quote to start this article with, because multiple studies have identified the fact that the studies used to approve this vaccine do not look for serious adverse effects. As a result, many young women have experienced drastic and debilitating changes after receiving the HPV vaccine. In rare cases it has even caused death.
One example comes from a study3 published in the British Medical Journal titled “Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination.” The study highlights an obvious fact, that “preservation of reproductive health is a primary concern in the recipient target group.” It is therefore ironic that the demonstration of ongoing and uncompromised safety for the ovary is, as the study points out, an “urgently required” need. You would think that the vaccine manufactures would look into this before approving it as completely safe. The abstract concludes by stating that “this matter needs to be resolved for the purposes of population health and public vaccine confidence.”
The main case in this study determined that, prior to the shots, the girl had healthy ovaries, and that there were no other identified factors besides Gardasil that could have been involved in her sudden sickness.
Another study conducted two years later by the same author documents three young women who developed premature ovarian insufficiency following quadrivalent human papillomavirus (HPV) vaccination presented to a general practitioner in rural New South Wales, Australia.
The study points out how…
further studies are required to make any claims of ovary complications. Principles of informed consent, population health, and vaccine confidence require careful, rigorous and independent research to establish ovarian safety following HPV.
This information alone warrants further studies, and this is exactly what the corporation avoids. They do not want to look for or conduct studies that link the HPV vaccine to such a major issue like ovarian failure, no matter how rare it is. It really puts into question whether or not it’s even worth vaccinating your child with the HPV vaccine.
Adverse effects have been reported around the world, and they are, according to many experts, like Dr. Diane Harper, far more common than what we are made to believe through the literature.
As a result of all these complications and reports of young girls who’ve had their lives destroyed, the American College of Paediatrics put out a statement regarding the matter last year:
It has recently come to the attention of the College that one of the recommended vaccines could possibly be associated with the very rare but serious condition of premature ovarian failure (POF), also known as premature menopause. There have been two case report series (3 cases each) published since 2013 in which post-menarcheal adolescent girls developed laboratory documented POF within weeks to several years of receiving Gardasil, a four-strain human papillomavirus vaccine (HPV4).
The document pointed out something that should have been addressed before this vaccine was administered en masse. Firstly, long term ovarian function was not assessed in either the original rat safety studies or the human vaccine trials. Secondly, most primary care physicians remain unaware of a possible association between HPV4 and POF and may not consider reporting POF cases or prolonged missing menstrual periods to the Vaccine Adverse Event Reporting System (VAERS).
Thirdly, potential mechanisms of action have been postulated based on autoimmune associations with the aluminum adjuvant used and previously documented ovarian toxicity in rats from another component, polysorbate 80. Lastly, it emphasized that, since licensure of Gardasil in 2006, there have been about 213 VAERS reports involving amenorrhea, POF or premature menopause, 88% of which have been associated with Gardasil.4
Another study published in the journal Pediatrics5 found that many paediatricians don’t strongly recommend the HPV vaccine. It found that a large percentage of pediatricians and family doctors—nearly one third of those surveyed—are not strongly recommending the HPV vaccine to parents and preteens, which is why, as illustrated by the study, HPV vaccination rates continue to drop.
Prior to this, another study was published in the journal Cancer Epidemiology in 2015. Written by Melissa B. Gilkey, an assistant professor at Harvard Medical School, the study was designed to assess how physicians recommend the HPV vaccine. The authors were surprised to find that…
physicians so often reported recommending HPV vaccination inconsistently, behind schedule, or without urgency. Of the five communication practices we assessed, about half of physicians reported two or more practices that likely discourage timely HPV vaccination.6
This study found that 27% of physicians across the United States do not strongly endorse HPV vaccination, and 26% do not give the vaccinations to girls on time as recommended. Approximately 59% of physicians recommended it for adolescents.
Note: This article was reprinted with the author’s permission. It was originally published by Collective Evolution.
1 Sekiguchi K, Yasui N, Kowa H, Kanda F, Toda T. Two Cases of Acute Disseminated Encephalomyelitis Following Vaccination Against Human Papilloma Virus. Intern Med 2016 Nov. 1, 2016; 55(21): 3181–3184.
2 Dr. Lucija Tomlijenovic: Adverse Reaction Studies—One More Girl Excerpts. YouTube May 2, 2014 (published).
3 Little DT, Grenville Ward HR. Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination. BMJ Case Reports 2012; doi:10.1136/bcr-2012-006879.
4 New Concerns about the Human Papillomavirus Vaccine. American College of Pediatricians January 2016.
5 Allison MA, Hurley LP, Markowitz L, Crane LA, Brtnikova M, Beaty BL, Snow M, Cory J, Stokley S, Roark J, Kempe A. Primary Care Physicians’ Perspectives About HPV Vaccine. Pediatrics January 2016.
6 Many U.S. Physicians Communicate With Parents in Ways That May Discourage HPV Vaccination. American Association for Cancer Research Oct. 22, 2015.